Patents by Inventor Thomas WURLITZER

Thomas WURLITZER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11951042
    Abstract: A device and method for the pre-display of a spot pattern to be applied for a laser treatment of the eye. The spot patterns to be applied are displayed to the operator in advance with the aid of a target beam. The device for the pre-display of a spot pattern to be applied for a laser treatment of the eye includes a laser system and a scanning system for generating a target beam. Here, the laser system and the scanning system for generating the target beam are formed to generate one or more lines which overlie all the spots of the spot pattern of a planned laser treatment. The device and method are suitable for laser treatment of the retina, the trabecular meshwork as well as other regions. Here, it is irrelevant whether what the laser treatment to be applied is.
    Type: Grant
    Filed: April 4, 2019
    Date of Patent: April 9, 2024
    Assignee: Carl Zeiss Meditec AG
    Inventors: Manfred Dick, Gerald Kunath-Fandrei, René Denner, Thomas Wurlitzer
  • Patent number: 11766357
    Abstract: A device for superimposing parameters and/or image data in the stereoscopic observation path of ophthalmological devices relates to an apparatus for reflecting relevant parameters and/or image data into the stereoscopic observation beam path of ophthalmic devices, for example for therapeutic laser treatments of an eye. The device includes an additional micro-display, which is connected to the control unit, and a beam deflection element for reflecting the parameters and/or image data shown on the micro-display into the stereoscopic observation beam path, which are for example arranged in the parallel beam path. Even though the apparatus is intended for ophthalmic devices for therapeutic laser treatment in the eye, it can also be used, in principle, for ophthalmic devices for examination, diagnosis and surgical interventions.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: September 26, 2023
    Assignee: Carl Zeiss Meditec AG
    Inventors: Manfred Dick, Gerald Kunath-Fandrei, René Denner, Thomas Wurlitzer, Rolf Teuscher
  • Patent number: 11660231
    Abstract: A method for a minimally invasive, cell-selective laser therapy on the eye. The method, based on a short-pulse laser system, allows for different selective types of therapy on the eye. The method is based on a frequency-doubled, continuously working solid-state laser including a pump source and a control unit. The control unit regulates the pump source such that the solid-state laser emits individual pulses with pulse lengths ranging from 50 ns to continuous, wherein pulse lengths ranging from 50 ns to 50 ?s are provided for selective therapies and pulse lengths ranging from 50 ?s to continuous are provided for coagulative or stimulating therapies, in particular in the range from 1 ms to 500 ms. The proposed method enables a selective treatment of melanin-containing cells in the different areas of the eye via the targeted control of the pump source.
    Type: Grant
    Filed: March 16, 2021
    Date of Patent: May 30, 2023
    Assignee: Carl Zeiss Meditec AG
    Inventors: Manfred Dick, Gerald Kunath-Fandrei, René Denner, Thomas Wurlitzer
  • Publication number: 20210196519
    Abstract: A method for a minimally invasive, cell-selective laser therapy on the eye. The method, based on a short-pulse laser system, allows for different selective types of therapy on the eye. The method is based on a frequency-doubled, continuously working solid-state laser including a pump source and a control unit. The control unit regulates the pump source such that the solid-state laser emits individual pulses with pulse lengths ranging from 50 ns to continuous, wherein pulse lengths ranging from 50 ns to 50 ?s are provided for selective therapies and pulse lengths ranging from 50 ?s to continuous are provided for coagulative or stimulating therapies, in particular in the range from 1 ms to 500 ms. The proposed method enables a selective treatment of melanin-containing cells in the different areas of the eye via the targeted control of the pump source.
    Type: Application
    Filed: March 16, 2021
    Publication date: July 1, 2021
    Inventors: Manfred DICK, Gerald KUNATH-FANDREI, René DENNER, Thomas WURLITZER
  • Publication number: 20210154048
    Abstract: A device and method for the pre-display of a spot pattern to be applied for a laser treatment of the eye. The spot patterns to be applied are displayed to the operator in advance with the aid of a target beam. The device for the pre-display of a spot pattern to be applied for a laser treatment of the eye includes a laser system and a scanning system for generating a target beam. Here, the laser system and the scanning system for generating the target beam are formed to generate one or more lines which overlie all the spots of the spot pattern of a planned laser treatment. The device and method are suitable for laser treatment of the retina, the trabecular meshwork as well as other regions. Here, it is irrelevant whether what the laser treatment to be applied is.
    Type: Application
    Filed: April 4, 2019
    Publication date: May 27, 2021
    Applicant: Carl Zeiss Meditec AG
    Inventors: Manfred DICK, Gerald KUNATH-FANDREI, René DENNER, Thomas WURLITZER
  • Patent number: 10973687
    Abstract: A method for a minimally invasive, cell-selective laser therapy on the eye. The method, based on a short-pulse laser system, allows for different selective types of therapy on the eye. The method is based on a frequency-doubled, continuously working solid-state laser including a pump source and a control unit. The control unit regulates the pump source such that the solid-state laser emits individual pulses with pulse lengths ranging from 50 ns to continuous, wherein pulse lengths ranging from 50 ns to 50 ?s are provided for selective therapies and pulse lengths ranging from 50 ?s to continuous are provided for coagulative or stimulating therapies, in particular in the range from 1 ms to 500 ms. The proposed method enables a selective treatment of melanin-containing cells in the different areas of the eye via the targeted control of the pump source.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: April 13, 2021
    Assignee: Carl Zeiss Meditec AG
    Inventors: Manfred Dick, Gerald Kunath-Fandrei, René Denner, Thomas Wurlitzer
  • Publication number: 20200268555
    Abstract: A device for superimposing parameters and/or image data in the stereoscopic observation path of ophthalmological devices relates to an apparatus for reflecting relevant parameters and/or image data into the stereoscopic observation beam path of ophthalmic devices, for example for therapeutic laser treatments of an eye. The device includes an additional micro-display, which is connected to the control unit, and a beam deflection element for reflecting the parameters and/or image data shown on the micro-display into the stereoscopic observation beam path, which are for example arranged in the parallel beam path. Even though the apparatus is intended for ophthalmic devices for therapeutic laser treatment in the eye, it can also be used, in principle, for ophthalmic devices for examination, diagnosis and surgical interventions.
    Type: Application
    Filed: September 28, 2018
    Publication date: August 27, 2020
    Applicant: Carl Zeiss Meditec AG
    Inventors: Manfred DICK, Gerald KUNATH-FANDREI, René DENNER, Thomas WURLITZER, Rolf TEUSCHER
  • Publication number: 20190117461
    Abstract: A method for a minimally invasive, cell-selective laser therapy on the eye. The method, based on a short-pulse laser system, allows for different selective types of therapy on the eye. The method is based on a frequency-doubled, continuously working solid-state laser including a pump source and a control unit. The control unit regulates the pump source such that the solid-state laser emits individual pulses with pulse lengths ranging from 50 ns to continuous, wherein pulse lengths ranging from 50 ns to 50 ?s are provided for selective therapies and pulse lengths ranging from 50 ?s to continuous are provided for coagulative or stimulating therapies, in particular in the range from 1 ms to 500 ms. The proposed method enables a selective treatment of melanin-containing cells in the different areas of the eye via the targeted control of the pump source.
    Type: Application
    Filed: April 7, 2017
    Publication date: April 25, 2019
    Applicant: Carl Zeiss Meditec AG
    Inventors: Manfred DICK, Gerald Kunath-Fandrei, René DENNER, Thomas WURLITZER